We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Predicting Death Risk After a Torn Aorta

By HospiMedica staff writers
Posted on 07 Aug 2007
A new study proposes an original way to predict post-hospital death risk for aortic dissection patients, and a new model for the mechanism behind that risk. More...


Researchers at the University of Michigan (U-M; Ann Arbor, USA) cardiovascular center conducted a study that involved data from 201 patients with aortic dissections in their descending aortas, who survived to hospital discharge and were followed for up to three years or until their deaths as part of IRAD, the International Registry of Acute Aortic Dissection.

The study focused on a phenomenon called the "false lumen,” created when the presence of blood clots causes the layers of the aorta to separate, like an onion. The false lumen runs alongside the "true” lumen, the aorta. As blood enters the false lumen from the top of the tear in the aorta, it gets trapped inside the new channel. Often, small openings at the bottom of the newly formed channel will allow the blood to flow out. But if the openings are not large enough, blood flow inside the false lumen is slowed down, pressure increases, and clots begin to form.

The study shows that the risk of post-hospital death is more than two-and-a-half times greater for patients who experience partial clotting (thrombosis) of the false lumen, than for those whose false lumen is clear of clots, or "patent.” Patients whose false lumen is totally filled with clotted blood, an infrequent event, have an intermediate risk of death. The study was published in the July 26, 2007, issue of the New England Journal of Medicine (NEJM).

"It appears that this may be a new predictor of which patients are most at risk--knowledge that might help guide decisions about when it's wise to proceed with more aggressive treatment and when we can hold off,” said lead author Thomas Tsai, M.D., M.Sc., a U-M fellow in cardiovascular medicine. But more research is needed.

In addition to the IRAD data, the researchers are studying a false lumen model of aortic dissection using an artificial material that simulates conditions inside the aorta.
Data suggest that in a partially thrombosed false lumen, the systolic blood pressure (BP) is lower than the systolic pressure in the aorta, but that the diastolic pressure is higher--leading to a higher average (mean) pressure in the false lumen as compared to the BP in patients with either a patent or a completely thrombosed false lumen.


Related Links:
University of Michigan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.